Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

After many trips to the doctor's office, five-year-old Burton Hayes's asthma was finally under control with a medication ...

After some disappointing earlier results for GSK’s new asthma treatment Revlar Ellipta, the company has today announced some encouraging news. An open-label non-inferiority lung function study ...

DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

GSK's head of respiratory and immunology R&D, Kaivan Khavandi, said that the drug had achieved the "fundamental treatment goal in asthma" by slashing asthma attacks and hospitalisations.

[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been ... Chiesi, GlaxoSmithKline, MSD, Menarini, Novartis and Nycomed.

GSK sales hampered by slump in demand for key vaccine - The drugmaker said sales of Arexvy fell sharply in the third quarter, ...